Jagriti Upadhyay to Liraglutide
This is a "connection" page, showing publications Jagriti Upadhyay has written about Liraglutide.
Connection Strength
0.215
-
Farr OM, Upadhyay J, Rutagengwa C, DiPrisco B, Ranta Z, Adra A, Bapatla N, Douglas VP, Douglas KAA, Nolen-Doerr E, Mathew H, Mantzoros CS. Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies. Diabetes Obes Metab. 2019 11; 21(11):2459-2464.
Score: 0.154
-
Shah J, Makwana B, Panchal K, Patel V, Patel T, Khadke S, Verma A, Vivekanandan S, Kong Y, Upadhyay J, Dani SS, Ramsey KM, Ganatra S, Ramsey DJ. Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy. Am J Ophthalmol. 2026 Aug; 288:131-142.
Score: 0.061